Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but ...

Since 1999, the American opioid epidemic has killed more than half a million people, and the staggering majority have been ...

"We need to pass legislation that ensures patients have better access to FDA-approved, non-opioid pain management ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Opioids dull the sensation of pain in the brain and hijack the brain's reward system, triggering the release of dopamine and ...

Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...

NSAIDs should be considered as first-line treatment for children with acute pain, with ketamine and mid- to high-potency opioids as other effective options.

Congress and the Florida Legislature must eliminate cost disparities between opioid and non-opioid options.

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

According to a new study by WashU Medicine researchers, male and female rats with a chronic pain condition release different ...

During my time serving in the state legislature, I heard from numerous constituents impacted by the opioid crisis ...